InvestorsHub Logo

Bickema

09/14/17 10:45 AM

#1496 RE: DewDiligence #1495

Thank you Dew.

DewDiligence

09/15/17 10:10 AM

#1501 RE: DewDiligence #1495

Mavyret scripts for week ending 9/8/17 (from IMS)…

TRx: 185, +29% from prior week
NRx: 156, +14% from prior week

Note: Mavyret’s absolute script figures reported by IMS are low because IMS misses much of the public sector of the HCV market that ABBV is targeting.